Clinical Trial Update: Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant chemotherapy trial in early breast cancer compares epirubicin/cyclophosphamide/paclitaxel with or without gemcitabine in women awaiting su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN